ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.81
-0.16 (-1.60%)
At close: Oct 7, 2026, 4:00 PM EDT
9.69
-0.12 (-1.22%)
After-hours: Oct 7, 2026, 4:10 PM EDT
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year. That makes ImmuCell the world's 33,110th largest employer and 4,367th in the United States.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$420,213
Profits / Employee
$10,786
Market Cap
89.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pelthos Therapeutics | 92 |
| Acrivon Therapeutics | 76 |
| Neumora Therapeutics | 63 |
| Biomea Fusion | 37 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| Equillium | 15 |
| Cognition Therapeutics | 14 |
ICCC News
- 7 weeks ago - ImmuCell Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - ImmuCell Earnings release: Q2 2026 - Filings
- 7 weeks ago - ImmuCell Quarterly report: Q2 2026 - Filings
- 7 weeks ago - ImmuCell Slides: Q2 2026 - Filings
- 7 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 7 weeks ago - ImmuCell Slides: Investor presentation - Filings
- 2 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 3 months ago - Immucell reports preliminary Q2 revenue $7.2M - TheFly